Health
Coronavirus vaccine latest update: Oxford vaccine found “SAFE” in early trials; triggers immune system response – Times of India
Touted as one of the frontrunners in the race to develop a vaccine fit for human use, Oxford University’s vaccine candidate has been in the news recently owing to various media reports, which claim that the potential vaccine has shown extremely promising resu…
Currently, Phase III trials of the AZD1222 are being conducted in Brazil on thousands of volunteers to understand the safety and efficacy of the vaccine candidate. On the other hand, Serum Institute of India, which is the largest vaccine manufacturer of the world by volume, has teamed with UK drugmaker AstraZeneca to manufacturer 1 billion doses of COVID vaccine.
Adar Poonawalla, CEO of SII told PTI, “At present, we are working on the AstraZeneca Oxford vaccine which is undergoing phase III cli…
-
General21 hours agoVote counting begins for Townsville mayoral by-election
-
General23 hours agoThree NT residents charged with fraud over alleged $71 million Defence contract scheme
-
General19 hours agoEngland completes sole Ashes warm-up match with flurry of runs to Ollie Pope, Joe Root
-
Noosa News23 hours agoLGAQ motions become voice for community